Marlous R. Dillingh - Concepedia

Author

Marlous R. Dillingh

Centre for Human Drug Research

Also Known As

M.R. Dillingh, Marlous Dillingh, Marlous R Dillingh, Marlous R. Dillingh

Publications

324

Citations

H-Index

Concepts

All Affiliations

Centre for Human Drug Research GBS Leiden Leiden University Medical Center Erasmus MC Erasmus University Rotterdam

About

Marlous R. Dillingh is an author at Centre for Human Drug Research specializing in medicine, inflammation, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	137
2	Health Sciences	1	1	15
3	Allergy	1	1	24
4	Diabetes	1	1	15
5	Endocrinology	1	1	15

Marlous R. Dillingh

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis Marlous R. Dillingh, Bernt van den Blink, Matthijs Moerland, Pulmonary Pharmacology & Therapeutics Advanced Lung DiseaseHealthy VolunteersPulmonary Alveolar ProteinosisPathologyPulmonary Fibrosis	2013	98
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy Bernt van den Blink, Marlous R. Dillingh, Leo C. Ginns, European Respiratory Journal	2016	96
Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers Marlous R. Dillingh, Eveline P. van Poelgeest, Karen E. Malone, Journal of Inflammation	2014	55
Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia Eveline P. van Poelgeest, Marlous R. Dillingh, Marieke de Kam, Journal of Pharmacological and Toxicological Methods Endothelial Cell PathobiologyInflammationExperimental Human EndotoxemiaRenal FunctionAllergy	2017	24
Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts Tessa Niemeyer‐van der Kolk, Marlous R. Dillingh, Rianne Rijneveld, Journal of the European Academy of Dermatology and Venereology	2017	22
Safety, tolerability and pharmacokinetic characterisation of DACRA KBP‐042 in healthy male subjects Kim Henriksen, Karen Broekhuizen, Wadim M. I. de Boon, British Journal of Clinical Pharmacology PharmacotherapyInsulin SignalingTarget Receptor EngagementObesityMetabolic Syndrome	2021	15
Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics Marlous R. Dillingh, Joannes A. A. Reijers, Karen E. Malone, Frontiers in Immunology	2016	12

Page 1